Literature DB >> 21113375

Upstream therapy in patients with early atrial fibrillation: The relevance of the Routine versus Aggressive upstream rhythm Control for prevention of Early atrial fibrillation in heart failure (RACE 3) study.

I C Van Gelder1, M D Smit, M Alings, H J G M Crijns.   

Abstract

Entities:  

Year:  2010        PMID： 21113375      PMCID： PMC2989488          DOI： 10.1007/s12471-010-0827-9

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


× No keyword cloud information.
  10 in total

1.  Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure.

Authors:  Akiko Shiroshita-Takeshita; Bianca J J M Brundel; Brett Burstein; Tack-Ki Leung; Hideo Mitamura; Satoshi Ogawa; Stanley Nattel
Journal:  Cardiovasc Res       Date:  2007-01-11       Impact factor: 10.787

Review 2.  Upstream therapy of atrial fibrillation.

Authors:  Marcelle D Smit; Isabelle C Van Gelder
Journal:  Expert Rev Cardiovasc Ther       Date:  2009-07

3.  Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction.

Authors:  Paul Milliez; Noeleen Deangelis; Catherine Rucker-Martin; Antoine Leenhardt; Eric Vicaut; Estelle Robidel; Philippe Beaufils; Claude Delcayre; Stéphane N Hatem
Journal:  Eur Heart J       Date:  2005-09-01       Impact factor: 29.983

4.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

Authors:  A John Camm; Paulus Kirchhof; Gregory Y H Lip; Ulrich Schotten; Irene Savelieva; Sabine Ernst; Isabelle C Van Gelder; Nawwar Al-Attar; Gerhard Hindricks; Bernard Prendergast; Hein Heidbuchel; Ottavio Alfieri; Annalisa Angelini; Dan Atar; Paolo Colonna; Raffaele De Caterina; Johan De Sutter; Andreas Goette; Bulent Gorenek; Magnus Heldal; Stefan H Hohloser; Philippe Kolh; Jean-Yves Le Heuzey; Piotr Ponikowski; Frans H Rutten
Journal:  Eur Heart J       Date:  2010-08-29       Impact factor: 29.983

Review 5.  Current concepts in the pathogenesis of atrial fibrillation.

Authors:  Antonios Kourliouros; Irina Savelieva; Anatoli Kiotsekoglou; Marjan Jahangiri; John Camm
Journal:  Am Heart J       Date:  2008-12-24       Impact factor: 4.749

6.  Exercise training in patients with severe chronic heart failure: impact on left ventricular performance and cardiac size. A retrospective analysis of the Leipzig Heart Failure Training Trial.

Authors:  Sandra Erbs; Axel Linke; Stephan Gielen; Eduard Fiehn; Claudia Walther; Jiangtao Yu; Volker Adams; Gerhard Schuler; Rainer Hambrecht
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2003-10

7.  Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study.

Authors:  Dariush Mozaffarian; Curt D Furberg; Bruce M Psaty; David Siscovick
Journal:  Circulation       Date:  2008-08-04       Impact factor: 29.690

8.  Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH).

Authors:  M F Piepoli; C Davos; D P Francis; A J S Coats
Journal:  BMJ       Date:  2004-01-16

9.  Valsartan for prevention of recurrent atrial fibrillation.

Authors:  Marcello Disertori; Roberto Latini; Simona Barlera; Maria Grazia Franzosi; Lidia Staszewsky; Aldo Pietro Maggioni; Donata Lucci; Giuseppe Di Pasquale; Gianni Tognoni
Journal:  N Engl J Med       Date:  2009-04-16       Impact factor: 91.245

Review 10.  Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode.

Authors:  Francisco G Cosio; Etienne Aliot; Giovanni Luca Botto; Hein Heidbüchel; Christoph Johan Geller; Paulus Kirchhof; Jean-Claude De Haro; Robert Frank; Julian Perez Villacastin; Johan Vijgen; Harry Crijns
Journal:  Europace       Date:  2007-12-17       Impact factor: 5.214
  10 in total
  5 in total

Review 1.  Neuro-atriomyodegenerative origin of atrial fibrillation and superimposed conventional risk factors: continued search to configure the genuine etiology of "eternal arrhythmia".

Authors:  Petras Stirbys
Journal:  J Atr Fibrillation       Date:  2016-12-31

2.  Atrial fibrillation in heart failure: The sword of Damocles revisited.

Authors:  Muhammad A Khan; Fozia Ahmed; Ludwig Neyses; Mamas A Mamas
Journal:  World J Cardiol       Date:  2013-07-26

3.  Ablation for atrial fibrillation: CT overlay or standard electroanatomical mapping?

Authors:  E E van der Wall
Journal:  Neth Heart J       Date:  2012-08       Impact factor: 2.380

Review 4.  Rationale and current perspective for early rhythm control therapy in atrial fibrillation.

Authors:  Isabelle C Van Gelder; Laurent M Haegeli; Axel Brandes; Hein Heidbuchel; Etienne Aliot; Josef Kautzner; Lukasz Szumowski; Lluis Mont; John Morgan; Stephan Willems; Sakis Themistoclakis; Michele Gulizia; Arif Elvan; Marcelle D Smit; Paulus Kirchhof
Journal:  Europace       Date:  2011-07-22       Impact factor: 5.214

5.  Loss of proteostatic control as a substrate for atrial fibrillation: a novel target for upstream therapy by heat shock proteins.

Authors:  Roelien A M Meijering; Deli Zhang; Femke Hoogstra-Berends; Robert H Henning; Bianca J J M Brundel
Journal:  Front Physiol       Date:  2012-02-23       Impact factor: 4.566
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.